TTD | Drug: D0AM1S

Drug General Information
Drug ID	D0AM1S
Former ID	DIB001182
Drug Name	CCD-3693
Synonyms	CCD 3000 series, CoCensys; CCD-3393; Epalon series member (3693), CoCensys; Insomnia therapy, CoCensys/Searle
Drug Type	Small molecular drug
Indication	Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42]		Discontinued in Phase 1	[546165]
Company	Purdue Neuroscience Corp
Structure		Download 2D MOL 3D MOL
Formula	C22H33F3O2
Canonical SMILES	[C@@]12([C@H]([C@H]3[C@@H]([C@@H]4[C@@H](C[C@@](C(F)(F)<br />F)(CC4)O)CC3)CC2)CC[C@@H]1C(=O)C)C
CAS Number	CAS 162883-07-0
PubChem Compound ID	192705
Target and Pathway
Target(s)	GABA A receptor	Target Info	Modulator	[1572591]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
	GABAergic synapse
	Morphine addiction
	Nicotine addiction
Reactome	Ligand-gated ion channel transport
Reactome	GABA A receptor activation
WikiPathways	SIDS Susceptibility Pathways
	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
	Iron uptake and transport
References
Ref 546165	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006723)
Ref 1572591	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information